Rethinking Local Therapy for Rectal Cancer in the Era of Precision Oncology-When Less Is More

Affiliations

Aron Bercz et al. JAMA Surg. 2025.

. 2025 Jul 1;160(7):793-794.

doi: 10.1001/jamasurg.2025.1377.

¹ Colorectal Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

No abstract available

Comment in

Chemoradiotherapy and Local Excision vs Total Mesorectal Excision in T2-T3ab, N0, M0 Rectal Cancer: The TAUTEM Randomized Clinical Trial.
Serra-Aracil X, Pericay C, Cidoncha A, Badia-Closa J, Golda T, Kreisler E, Hernández P, Targarona E, Borda-Arrizabalaga N, Reina A, Delgado S, Espín-Bassany E, Caro-Tarrago A, Gallego-Plazas J, Pascual M, Álvarez-Laso C, Guadalajara-Labajo H, Otero A, Biondo S; TAUTEM Collaborative Group. Serra-Aracil X, et al. JAMA Surg. 2025 Jul 1;160(7):783-793. doi: 10.1001/jamasurg.2025.1398. JAMA Surg. 2025. PMID: 40434784 Clinical Trial.